CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 35 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $515,000 | -51.2% | 90,929 | -9.6% | 0.51% | -35.5% |
| Q3 2018 | $1,056,000 | -1.1% | 100,535 | +4.5% | 0.79% | -1.7% |
| Q2 2018 | $1,068,000 | +77.7% | 96,235 | +28.2% | 0.81% | +70.1% |
| Q1 2018 | $601,000 | +10.3% | 75,092 | +13.1% | 0.48% | +11.8% |
| Q4 2017 | $545,000 | +167.2% | 66,417 | +101.9% | 0.42% | +169.0% |
| Q3 2017 | $204,000 | +179.5% | 32,900 | +174.2% | 0.16% | +172.4% |
| Q2 2017 | $73,000 | – | 12,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
| Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
| GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
| Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
| SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
| Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
| Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
| Virtu Financial LLC | 19,653 | $49,000 | 0.00% |